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Background: Prevalence of metabolic syndrome is high and increasing in China. The causation of this disorder is,
yet, to be fully understood. Several studies with confirmatory factor analysis have been performed to investigate the
core of the disease in some races other than Chinese, and amongst the other studies, they have yielded a sound
model fit. This study was to evaluate and compare two single-factor models of the underlying factor structure of
metabolic syndrome in a Chinese population using confirmatory factor analysis.
Results: Findings showed that in a Chinese sample of 7,472 individuals, Model 1 (with waist circumference,
triglycerides/HDL-C ratio, fasting plasma glucose and mean artery pressure) yielded good level of fitness (SRMR <
0.08, CFI > 0.96 and RMSEA < 0.10) in men and women of all age groups; and Model 2 (with waist circumference,
triglycerides, fasting plasma glucose and systolic blood pressure) fitted well in men aged 18–34 and over 60 and in
all women, except in men of 35–59 (RMSEA = 0.142). In comparison, Model 2 were shown to be better fit (with
relative larger GFI and smaller AIC, BIC, CAIC, and EVIC) in women of all age groups and in men of 18–34 and over
60 years old; Model 1 had a better fit in men between 35 and 59.
Conclusions: This study suggests that the single-factor model of metabolic syndrome with waist circumference,
triglycerides, fasting plasma glucose and systolic blood pressure are plausible in women of all age groups and
young and senior men in Beijing. The model with waist circumference, triglycerides/HDL-C ratio, fasting plasma
glucose and mean artery pressure fits middle-aged men.
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The metabolic syndrome (MetS) is conceptualized as a
constellation of multiple, closely-related metabolic dis-
orders. It is a major global public health problem in
both developed and developing countries [1]. The com-
monly encompassed features of MetS are insulin resist-
ance, hypertension, abdominal obesity, and dyslipidemia
[1-4]. Those seemingly unrelated biological processes
have been proved to occur at a frequency higher than by
mere chance. In 1988, Reaven proposed an underlying* Correspondence: guoxiuh@ccmu.edu.cn
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reproduction in any medium, provided the orpathophysiological causation and named it as Syndrome
X [5]. And the syndrome appears to increase the risk of
developing cardiovascular disease and type 2 diabetes
mellitus [6-9]. Although, it has been known for at least
eighty years [10], the definition for MetS has been
developing with time – World Health Organization
(WHO) in 1999 [11], International Diabetes Federation
(IDF) in 2004 [2], US National Cholesterol Education Pro-
gram (NCEP) Adult Treatment Panel III (ATP III) in 2001
[12] and a modified edition in 2005 [13]. In China,
Chinese Diabetes Society (CDS) [14] and Joint Committee
for Developing Chinese Guidelines on Prevention and
Treatment of Dyslipidemia in Adults (JCDCG) [15] also
released their diagnosing criteria specifically for the
Chinese population in 2004 and 2007, respectively. In. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Means and standard deviations of physiological





Mean SD Mean SD
Height (cm) 169.8 6.4 159.1# 5.6
Weight (kg) 70.0 11.0 59.8# 9.2
Waist Curriculum (cm) 84.5 9.7 76.8# 9.3
Hip Curriculum (cm) 97.0 6.9 95.5# 7.3
Body Mass Index (kg/m2) 24.2 3.3 23.6# 3.5
Waist/hip Curriculum Ratio 0.87 0.06 0.80# 0.06
Systolic Blood Pressure* (mmHg) 128.8 15.6 120.8# 17.1
Diastolic Blood Pressure (mmHg) 80.3 10.3 76.9# 10.1
Mean Artery Pressure* (mmHg) 96.5 11.2 91.5# 11.8
Fasting Plasma Glucose* (mmol/L) 5.29 1.05 5.14# 0.83
Total Cholesterols (mmol/L) 4.56 0.94 4.53 0.86
Triglyceride* (mmol/L) 1.36 1.14 1.02# 0.76
HDL-C (mmol/L) 1.27 0.31 1.42# 0.30
LDL-C (mmol/L) 2.97 0.89 2.85# 0.82
TG/HDL-C Ratio* 1.22 1.47 0.80# 0.85
Creatinine (µmol/L) 83.86 14.23 66.4# 11.1
* These values were loge transformed in confirmatory factor analysis;
# These values are significant at P < 0.01 compared with male counterparts;
SD, standard deviation.
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was released [16]. In the statement, raised waist circumfer-
ence (WC), elevated triglycerides (TG), reduced high-
density lipoprotein cholesterol (HDL-C), elevated systolic
and/or diastolic blood pressure (SBP, DBP), and elevated
fasting plasma glucose (FPG) were included in the diagno-
sis criteria. WC, the indicator for central obesity, is de-
fined as population- or country-specific.
Though the definition has been agreed upon, the
mechanism of MetS is still controversial [17], such as
some declaring that insulin resistance might be the
major cause [5,18]. There is debate about the essence of
the MetS pertaining to which components are included
and what pathologic process is central to its occurrence.
The commonly included components are hypertension,
obesity, elevated blood glucose, and dyslipidemia. These
factors tend to cluster as a risk factor for the morbidity
of cardiovascular disease, type 2 diabetes mellitus, and
overall mortality [1,13].
In recent years, factor analysis has been applied to shed
some light on finding the “common soil” for the syndrome
[19]. Exploratory factor analysis (EFA), a multi-factorial
statistical procedure, is used to extract a relatively small set
of latent variables from the extensively observed ones. Ob-
served variables are directly measurable, while the latent
are the underlying factors. Studies with EFA indicate differ-
ences in the number of factors extracted and the variable
loadings on each factor. The inconsistence may be due to
the nature of EFA and the methods applied in the extrac-
tion of variables. The variables shared in common are as-
sumed to be the underlying latent variables [20].
Confirmatory factor analysis (CFA) is another way to
evaluate the factor structures of MetS based on the the-
oretical foundations set by EFA [21]. It is used to analyze
one or more latent causative factors underlying a con-
cept, i.e. MetS in our study, by comparing the distribu-
tion and the established factor structure based on the
known concept [22].
With a priori selected factor models from previous re-
search, CFA can be used to compare competing models
of MetS using the same dataset to determine which of
the two or more hypothesized models fits best [23].
The aim of this study is to evaluate and compare two
competing models of metabolic syndrome using CFA in
a Chinese population. There are two single-factor
models for candidate: Model 1 is by Pladevall et al. and
Martinez-Vizcaino [24,25], with WC, TG/HDL-C ratio,
and mean arterial pressure (MAP) as factors, but
HOMA-IR (homeostasis model of assessment for insu-
lin resistance) or fasting insulin in the original models is
substituted by fasting plasma glucose referred to the
latest diagnosis criteria for MetS [16]; Model 2 is
presented by Li and Ford [26] with WC, TG, and SBP,
while fasting insulin is substituted by FPG.Results
Population profile
There were 16,711 individuals (87.0% of the total 19,216
subjects we selected) who finished the questionnaire
(6,658 men, 45.83 ± 14.47 years; 10,053 women, 40.77 ±
12.13 years; gender ratio: female/male = 1.51). There
were 688 subjects with no anthropometric, physiologic,
or blood biochemical characteristic measurements were
excluded. Afterwards, 8,551 people with anti-hypertensive,
anti-dyslipidemic, or anti-hyperglycemic treatment were
excluded. Therefore, 7,472 subjects were finally used for
the analysis (2,666 men, 40.83 ± 14.47 years; 4,806
women, 40.77 ± 12.13 years), and gender ratio female/
male was 1.80.
About 51.7% of male participants smoked every day
versus only 2.9% in female. And 41.1% of men drank al-
cohol at least once a week, versus 3.3% of women.
According to the last definition for MetS in 2009 [16],
elevated WC was observed in 28.7% in men and 34.9%
in women, elevated TG was seen in 23.4% of men and
10.5% of women; low HDL-C was detected in 15.9% of
men and 35.7% of women; elevated blood pressure was
observed in 46.3% of men and 29.3% of women; elevated
FPG was seen in 21.5% of men and 15.9% of women.
The prevalence of MetS, the cluster of three or more
metabolic risk factors, was 21.5% in men and 16.9% in
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shown in Table 1.
Confirmatory factor analysis (CFA)
CFA was performed with AMOS v7.0, and the loadings
for the factors in each model are shown in Figure 1 and
Figure 2. Factor loadings were required to be greater
than 0.30 and statistically significant (P < 0.05). In both
models, all factor loadings were statistically significant.
In Model 1, WC was the highest loading among the four
factors, while FPG was the least. The loadings of TG/
HDL-C ratio and MAP were very close. TG/HDL-C ratio
was a bit higher than MAP in men and senior women,
while this was opposite in young and middle-aged women.
In Model 2, WC was also the highest loading factor. TG
was at the second place in men and in young and senior
women; while SBP was the second highest loading factor
in middle-aged women. FPG had the lowest score in both
men and women.
Table 2 showed the fitness of models in each sex-age
group. A χ2 test was used to evaluate if the hypothesized
models fit the sample population. In either Model 1 or
Model 2, the χ2 test had a P > 0.05 in men and women
aged above 60. This indicated that the two single-models
did not explain all of the relations among the measured































Model 2    Male, 35
Figure 1 Two single-factor models for MetS for men in different age
circumference; TG/HDL-C, the ratio between triglyceride and high-density l
pressure; TG, triglyceride; SBP, systolic blood pressure. Models are grouped
transformed in CFA.prone to show a significant lack of model fit in studies
with large sample size (over 1000 subjects), it was fore-
seeable that large χ2 value might be produced, and its re-
sults cannot be merely assessed in isolation. As a result,
other indices were introduced. A model was considered
to have a good fit when the CFI is more than 0.960 [27]
and the SRMR is less than 0.080 [27]. The SRMR (stan-
dardized root mean square residual) was less than 0.080
in all age groups in Models 1 and 2. In Model 1, CFI
(comparative fit index) was greater than 0.960 in male,
and in female aged less than 60; in Model 2, CFI was
plausible in every group except men aged 35–59. A
model has a poor fit if RMSEA (root mean square error
of approximation) is greater than 0.100; a mediocre fit is
0.080-0.100; and 0.050-0.080 means a reasonable fit;
while a model has a good fit when the RMSEA is less
than 0.050 [27]. According to this criteria, only Model 2
had a poor fit in middle-aged men.
In Table 3, fit indices were compared between the two
competing models. GFI (goodness-of-fit index) showed
how well a theoretical matrix could explain the matrix
from a data sample. GFI ranges from 0 to 1, and a higher
score means a better fit [27]. Generally, GFI of more
than 0.90 indicates a good model fit. Both the models in
every age group had a sound GFI value. AIC (Akaike in-





































Model 2    Male, ≥60 n = 260
groups. Abbreviations: MetS, metabolic syndrome; WC, waist
ipoprotein cholesterol; FPG, fasting plasma glucose; MAP, mean arterial




























































Model 2    Female, ≥ 6000 n = 306
Figure 2 Two single-factor models for MetS for women in different age groups. Abbreviations: MetS, metabolic syndrome; WC, waist
circumference; TG/HDL-C, the ratio between triglyceride and high-density lipoprotein cholesterol; FPG, fasting plasma glucose; MAP, mean arterial
pressure; TG, triglyceride; SBP, systolic blood pressure. Models are grouped in different age ranges in both sexes. Values with asterisk (*) were loge
transformed in CFA.
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compare models with different latent variables. Models
with a smaller AIC indicates a better fit [27,28]. Model 2
had a relative smaller value of AIC in every age group
than Model 1, except in middle-aged men. BIC (Bayes
information criterion) is similar to AIC in that both are
derivatives of an information-theory based test. CAIC
(consistent version of AIC) takes into the consideration
of sample size effect. ECVI (expected cross-validation
index) concerns the overall error. The indices above
were used to compare fitness in different models [27].
Model 2 had a relative higher GFI and smaller AIC, BIC,
CAIC, and ECVI than Model 1 in women over 35 and
men in 18–34 and above 60; while in men of 35–59,
Model 1 had a better fit in all set of indices. For young
women, Model 2 had a larger GFI, smaller AIC and
ECVI, whereas Model 1 had a smaller BIC and CAIC.
Discussion
Our results show that although in the same ethnic
group, people from different sex-age groups must not be
confirmed as one defined model. A number of published
CFA studies have tested various hypothetical models,
including 1-factor, 2-factor, 4-factor and second-order
latent factor models [19-22,24], but there continues to
be debate regarding which model best represents the
factor structure for underlying cardiovascular risk factorclustering. But as a syndrome, there might be a core for
the obvious disorders, and the single-factor model would
be preferable.
In our study, WC is the leading factor for MetS. MetS
is based on insulin resistance, however, the HOMA-IR is
not available for this study, and WC is not the best but
the most used manifest for that. It is consistent with
former studies in other populations [24,29]. The models
applied in different age groups have a great deal to do
with the ultimate fit of the model. Regardless of how
well specified the model is or its goodness of fit, factor
analysis does not and cannot “prove” trait clustering or
its physiological mechanism. Even confirmatory analyses
are a function of a hypothetical model. In theory, there
are an infinite number of alternative models that could
fit data equally well or better and thereby produce the
same covariance matrix. This is known as the equivalent
models problem in structural equation modeling. Equiva-
lent models are of particular concern for metabolic syn-
drome research and theory because such equivalent
models may produce conflicting interpretations. In this
study, Models 1 and 2 are examples of such conflicting
models. In our study, Model 2 fitted the data in male of
18–34 and over 60 and in female of all age-groups,
whereas Model 1 fitted male subjects of 35–59.
A prior CFA study had tested models similar to 1 and
2, and found it to be valid and invariant across race and
Table 2 Summary of statistics and model fit indices
Model 1
χ2 df P value SRMR CFI RMSEA 90% CI RMSEA
Male
18-34 4.976 2 0.083 0.0212 0.991 0.045 <0.001, 0.096
35-59 8.255 2 0.016 0.0229 0.987 0.055 0.020, 0.096
≥60 3.910 2 0.142 0.0344 0.973 0.061 <0.001, 0.151
Female
18-34 12.617 2 0.002 0.0226 0.977 0.058 0.030, 0.091
35-59 38.287 2 <0.001 0.0263 0.969 0.079 0.058, 0.101
≥60 5.066 2 0.079 0.0334 0.938 0.071 <0.001, 0.151
Model 2
χ2 df P value SRMR CFI RMSEA 90% CI RMSEA
Male
18-34 7.047 2 0.030 0.0206 0.987 0.049 0.013, 0.091
35-59 57.212 2 <0.001 0.0516 0.849 0.142 0.112, 0.175
≥60 3.892 2 0.143 0.0318 0.968 0.060 <0.001, 0.150
Female
18-34 8.579 2 0.014 0.0187 0.982 0.046 0.018, 0.079
35-59 28.680 2 <0.001 0.0229 0.975 0.068 0.047, 0.090
≥60 3.107 2 0.212 0.0260 0.976 0.043 <0.001, 0.129
Table 3 Summary of models fit indices for two competing
models
Model 1
GFI AIC BIC CAIC ECVI 90% CI ECVI
Male
18-34 0.996 24.255 63.816 71.816 0.023 0.018, 0.036
35-59 0.986 58.367 100.135 108.135 0.043 0.030, 0.061
≥60 0.993 19.910 48.396 56.396 0.077 0.069, 0.115
Female
18-34 0.996 28.617 63.095 71.503 0.018 0.013, 0.028
35-59 0.994 54.287 102.141 110.141 0.019 0.013, 0.027
≥60 0.992 21.066 50.855 58.855 0.069 0.059, 0.104
Model 2
GFI AIC BIC CAIC ECVI 90% CI ECVI
Male
18-34 0.997 23.047 62.607 70.607 0.022 0.018, 0.034
30-59 0.981 73.211 114.981 122.981 0.054 0.038, 0.074
≥60 0.993 19.892 48.377 56.377 0.077 0.069, 0.115
Female
18-34 0.997 24.579 67.465 75.465 0.016 0.012, 0.024
35-59 0.995 44.680 92.534 100.534 0.015 0.011, 0.023
≥60 0.995 19.107 48.895 56.895 0.063 0.059, 0.092
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examined across sex [20,26], ethnicity [20,26], and age in
a male population [30]. It seems that the theoretical
model of MetS is consistent with few exceptions. In our
study, the models fit differently in specific sex-age group.
The concept of a single underlying factor that influences
the expression of all observed traits is plausible. How-
ever, further longitudinal investigations are needed to
explore the invariance of measurement, and to test the
model structure stability with time.
This study indicated that the factor structure under-
lying the clustering of MetS in adults is varied in a
population as Beijing’s. The lack of fit and instability of
the two models presented indicated that there might be
variable components in the structure of MetS. There-
fore, more research could be carried out to explore into
the etiology of MetS.
There are also some limitations to this study. First, ana-
lyses were performed using cross-sectional data. There-
fore, a temporal relationship was established between the
studied MetS components. Second, as the requirement of
CFA, the entry could only be analyzed with no missing
value. Third, as the lack of measurement of fasting insulin,
HOMA-IR and other indicators were not available to
build the mature models such as the Pladevall et al.’s, Li
and Ford’s, and Martinez-Vizcaino et al.’s.
Conclusions
Our study confirms that MetS is a multi-factorial syn-
drome, and it suggests that there could be some patterns
of common causation for the core components of MetS.
This study preformed CFA in a Chinese population in
Beijing, and suggests that the single-factor model of meta-
bolic syndrome with WC, TG, FPG and SBP is plausible
in women of all age group, and fits men in young adult-
hood and senior as well. The model with WC, TG/HDL-C
ratio, FPG and MAP has better fit in men of middle-age.
Methods
Survey methodology and laboratory tests
In 2005, a surveillance of risk factors for non-
communicable diseases was conducted by Municipal
Health Bureau and the Centers for Disease Control and
Prevention (CDC) in Beijing, China. The cross-sectional
study employed proportional multistage cluster random
sampling design and selected 19,216 persons aged ≥ 18
year-old who have lived in the city for at least six
months. The survey was carried out during August and
September, 2005. It included questionnaires, anthropo-
metric and blood pressure measures, blood biochemical
analysis. The questionnaire was composed of demo-
graphic profile as age, gender, educational background;
risk factors of non-communicable diseases including
smoking habit, alcohol consumption, diet, and physical
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hypertension, type 2 diabetes mellitus, dyslipidemia, and
overweight or obesity. The anthropometric measurements
included weight, height, waist and hip circumference;
blood pressure include systolic and diastolic pressures; and
the laboratory examinations included fasting plasma glu-
cose, total cholesterol, high-density lipoprotein cholesterol
(HDL-C), low-density lipoprotein cholesterol (LDL-C), and
creatinine. Detailed survey methodology, measurements
and laboratory tests and was depicted elsewhere in 2010
[31]. This study was approved by the ethics committee of
the Capital Medical University of China, and performed in
accordance with the principles of Declaration of Helsinki
(reference number: 2013SY26).
Inclusion criteria and layered approach
Primarily, there were 16,711 persons included in the
database. 688 subjects with any missing value in sex,
waist curriculum, systolic blood pressure, diastolic blood
pressure, fasting plasma glucose, triglycerides, or HDL-C
were excluded. 8,551 people with medication treatment
within two weeks of tests were also excluded. At last,
7,472 individuals were remained under CFA. The age
groups were divided as “18-34 years”,“35-59 years” and
“over 60 years”, which stood for young, middle-aged,
and senior population, and models were analyzed in
each age-group. There were 1,038, 1,368 and 260 male
subjects in young, middle-aged and senior age-group, re-
spectively; and 1,573, 2,927 and 306 female subjects in
each age-group, respectively.
Statistical analysis
Continuous variables were expressed as means and
standard deviations (SD), and discrete variables were
presented as proportions. The study population met all
requirements for factor analysis. In testing the normality
assumption, five variables were found to have a high
skewness – TG, TG/HDL-C ratio, FPG, SBP and MAP;
these variables were transformed with a natural log func-
tion. The dichotomous variables used to define MetS
risk factors were categorized by cut points of the latest
definition [16]. The detailed diagnosis criteria are as
follows:
▪Obesity: ≥ 85 cm in men; ≥ 80 cm in women;
▪Raised TG level (drug treatment for raised TG level is
an alternative indicator): ≥ 150 mg/dL (1.7 mmol/L);
▪Reduced HDL-C level (drug treatment for reduced
HDL-C level is an alternative indicator): < 40 mg/dL
(1.0 mmol/L) in men; < 50 mg/dL (1.3 mmol/L) in
women;
▪Raised blood pressure (antihypertensive drug treatment
in a patient with a history of hypertension is an
alternate indicator): SBP ≥ 130 and/or DBP ≥ 85 mmHg;▪Raised FPG level (drug treatment of raised glucose is
an alternative indicator): ≥ 100 mg/dL (5.6 mmol/L);
▪Participants fulfilling at least three out of these five
components were diagnosed as having MetS.
The database was established by EpiData v3.02. The
statistical analyses were performed using Statistical Pack-
age of Social Science for Windows v13.0 (SPSS Inc.,
Chicago, IL, USA). Statistical significance was set as P <
0.05.
To examine the construct validity of the two competing
models for MetS, the CFA performed with maximum like-
lihood estimation using AMOS v7.0 (AMOS Development
Co., Crawfordville, FL, USA).
Consent
Written informed consent was obtained from the patient
for publication of this report and any accompanying
images.
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